About us

Eurivex Ltd is an EU Investment Firm regulated by the Cyprus Securities & Exchange Commission (CySEC), number 114/10, licensed to offer Reception, Transmission and Execution of Orders, Dealing on Own Account and safe-keeping of client financial instruments.

Eurivex was established in 2009 and received its regulatory license from CySEC in March 2010.

Eurivex has 8 operational departments, independent Compliance, AML and Risk Officers and the external auditors are Grant Thornton Cyprus.

The 5-member Board of Directors of Eurivex is made up of 3 Executives and 2 Non- Executive Independent Directors vetted and approved by CySEC. The Board and Management team of Eurivex are all licensed professionals, Cypriot nationals and resident of Cyprus.

Eurivex is a member of the Cyprus Investor’s Protection Fund.

The headquarters of Eurivex is based in Nicosia, the capital of Cyprus. Eurivex also maintains a Representative Office in London.

Who we are:

The composition of the Board of Directors of Eurivex is as follows:

Shavasb Bohdjalian – Executive Director

Antranic Keremidjian – Executive Director

Greta Bohdjalian – Executive Director

Anna Stylianou – Non-Executive Independent Director

Christos Michaelides - Non-Executive Independent Director

Senior Management team of Eurivex is as follows:

Shavasb Bohdjalian – CEO, Head of Dealing on Own Account, Listings

Antranic Keremidjian – CFO, Head Depository and Custody

Greta Bohdjalian – Head of Customer Support, Reception, Transmission & Execution

Olga Kiremidjian – Compliance and AML Officer

Dr. George Ioannides – Risk Manager

Kyriacos Savva – Internal Auditor

Natalia Georgalla – Depository and Custody, Customer Support

Gregory Kiremidjian – Head of Accounts, Depository and Custody

Disclaimer & Regulatory information
Eurivex Ltd is a Cyprus Investment Firm, authorized and regulated by the Cyprus Securities and Exchange Commission (CySEC), License number 114/10. Company Reg. HE 255430. Headquartered and based in Cyprus, member of EU.

Risk warning: Investing in financial instruments and other derivatives involves a high degree of risk and may not be suitable to all investors. Trading in such financial instruments can result in both an increase and decrease in capital. If you invest through Eurivex Ltd, the value of investments may go down and your capital will be at risk. Eurivex Ltd operates a secondary market but there is no guarantee that all buy/sell orders will be completed at the desired prices and there is a risk that an order may not be completed in the Eurivex secondary market if there is no matching order. There is no guarantee that you will be able to exit early by selling your investment. Eurivex Ltd does not provide investment, tax or legal advice. If you are unsure about the suitability of an investment, you should speak to a financial adviser. Please refer to our Risk Warning available on our web site for further information.